Concepedia

Publication | Open Access

Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer

DOIFull Paper Access

23

Citations

0

References

2015

Year

Keun‐Wook Lee, Kyung Hee Lee, Dae Young Zang, Young Iee Park, Dong Bok Shin, Jin Won Kim, Seock‐Ah Im, Sung Ae Koh, Kyung‐Sang Yu, Joo‐Youn Cho,
The Oncologist

Abstract

Oraxol exhibited modest efficacy and favorable toxicity profiles as second-line chemotherapy for GC.